Budapest – June 19, 2025 | Semmelweis University once again hosted the internationally renowned C1-Inhibitor Deficiency and Angioedema Workshop, drawing 412 professionals from 43 countries between May 29 and June 1. Now in its 14th edition, the event has become a major fixture in global rare disease research and clinical exchange.
The workshop was chaired by Dr. Henriette Farkas, professor at Semmelweis University’s Department of Internal Medicine and Hematology and head of the Hungarian Angioedema Center of Reference and Excellence. In his welcome address, Rector Dr. Béla Merkely emphasized the university’s pride in hosting such a prestigious event, which was co-founded in 1999 by Dr. Farkas and Dr. Lilian Varga.
This year’s programme featured:
- 49 oral presentations across seven sessions
- 58 scientific posters
- Keynotes from leading experts, including Nobel laureate Dr. Katalin Karikó
Research highlights included the role of novel inhibitor proteins, advances in genetic diagnostics, AI-driven patient registry models, and the updated pediatric guidelines for hereditary angioedema (HAE), developed by an international panel chaired by Dr. Farkas.
Semmelweis-affiliated researchers contributed extensively, with studies focusing on the Hungarian patient population, including surgical trends, gender-based disease patterns, and newly identified genetic variants.
Awards presented included the “For HAE Patients” Prize to Dr. Laurence Bouillet (France) and a posthumous tribute to Dr. Marcus Maurer (Germany). Four outstanding young speakers, including Lili Voloncs-Mindszenthy of Semmelweis University, received €2,500 each for their contributions.
The workshop concluded with a summary lecture by Prof. Avner Reshef (Israel) and was organized with the support of Diamond Congress Ltd.
Source: Semmelweis University
About the Author
